INTERCEPT PHARMACEUTICALS, INC. Annual Return On Equity in % from 2013 to 2022

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Intercept Pharmaceuticals, Inc. quarterly/annual Return On Equity history and growth rate from 2013 to 2022.
  • Intercept Pharmaceuticals, Inc. Return On Equity for the quarter ending September 30, 2023 was -82.2 %, a 18.5% increase year-over-year.
  • Intercept Pharmaceuticals, Inc. annual Return On Equity for 2022 was -164 %, a 433% decline from 2021.
  • Intercept Pharmaceuticals, Inc. annual Return On Equity for 2021 was 49.2 %, a 81.6% decline from 2020.
  • Intercept Pharmaceuticals, Inc. annual Return On Equity for 2020 was 268 %.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2022 -164 -213 -433% Jan 1, 2022 Dec 31, 2022
2021 49.2 -219 -81.6% Jan 1, 2021 Dec 31, 2021
2020 268 +724 Jan 1, 2020 Dec 31, 2020
2019 -456 +135 +22.9% Jan 1, 2019 Dec 31, 2019
2018 -591 -323 -121% Jan 1, 2018 Dec 31, 2018
2017 -268 -167 -165% Jan 1, 2017 Dec 31, 2017
2016 -101 -63.3 -168% Jan 1, 2016 Dec 31, 2016
2015 -37.8 +143 +79.1% Jan 1, 2015 Dec 31, 2015
2014 -180 -103 -133% Jan 1, 2014 Dec 31, 2014
2013 -77.4 Jan 1, 2013 Dec 31, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.